ArticleThe European respiratory journal2022
The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
Article in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.
- A systematic review of the relation between ten potential occupational sensitizing exposures and asthma.Scandinavian journal of work, environment & health · 2025Pooled it
- The epidemiology of asthma in Mainland China: a systematic review and meta-analysis.BMC public health · 2024Pooled it
- Uncontrolled Status, Disease Burden, and Associated Risk Factors Among Patients with Asthma Receiving Medium-to-High Dose ICS or ICS/LABA: A Retrospective Analysis.Advances in therapy · 2026Observational
- From mild-to-moderate to severe asthma: risk factors and patient profiles from the NORDSTAR cohort.American journal of respiratory and critical care medicine · 2026Observational
- Worldwide Impact of Human Development and Inequality on the Prevalence of Asthma, Rhinoconjunctivitis and Eczema. Global Asthma Network's Ecological Study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026Article
- Global Asthma Disparities: Deciphering the Multifaceted Environmental Exposome Between Eastern and Western Populations.Clinical reviews in allergy & immunology · 2026Review
- Factors Associated with Domain-Specific Asthma-Related Quality of Life in Adults with Asthma.Healthcare (Basel, Switzerland) · 2026Article
- Postoperative pulmonary complications and associated risk factors in children with asthma undergoing surgery.BMC pulmonary medicine · 2026Observational
- Evaluation of the effectiveness of outdoor field-based teaching in training allergy specialists to identify allergenic plants.BMC medical education · 2026Article
- Association of COVID-19 with hay fever symptoms and preventive behaviors using a digital cohort study with AllerSearch.Scientific reports · 2026Article
- Expanding role of cell-free DNA for the early diagnosis and monitoring of pulmonary diseases.Chinese medical journal · 2026Review
- Association Between Mediterranean Diet and the Incidence of Adult-Onset Asthma in the SUN Project: A Spanish Prospective Cohort Study.Respirology (Carlton, Vic.) · 2026Article
- Effect of initiation treatment timing on efficacy ofThe World Allergy Organization journal · 2026Article
- Interpretable machine learning based decision tree model for predicting obstructive airway disease in a large non-smoking health screening population.Scientific reports · 2026Article
- Allergic Diseases in Common Variable Immunodeficiency: A Prospective Cross-Sectional Study on Prevalence and Allergy Biomarkers of Clinical Phenotypes.Scandinavian journal of immunology · 2026Article
- A beneficial environment promotes immune resilience through epigenetic regulation.Science advances · 2026Article
- South African Thoracic Society position statement on asthma in children, adolescents and adults.African journal of thoracic and critical care medicine · 2026Article
- Prevalence of asthma and associated factors among 6- and 7-year-old schoolchildren: a cross-sectional study in Santiago Island, Cabo Verde, 2022.Frontiers in pediatrics · 2026Article
- Differences in Type 2 Phenotype and Clinical Characteristics of Adult Asthma Patients with Different Severity, Across GINA Step 1 to 5 Asthma.Journal of asthma and allergy · 2026Article
- Efficacy ofJournal of asthma and allergy · 2026Article
22 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
19 authors at 8 institutions in 8 countries.
Funding
Abstract
aimsAsthma, hay fever and eczema are three common chronic conditions. There have been no recent multi-country data on the burden of these three conditions in adults; the aims of this study are to fill this evidence gap.
methodsThe Global Asthma Network Phase I is a multi-country cross-sectional population-based study using the same core methodology as the International Study of Asthma and Allergies in Childhood Phase III. It provides data on the burden of asthma, hay fever and eczema in children and adolescents, and, for the first time, in their parents/guardians.
resultsData were available from 193 912 adults (104 061 female; mean±sd age 38±7.5 years) in 43 centres in 17 countries. The overall prevalence (range) of symptoms was 6.6% (0.9-32.7%) for current wheeze, 4.4% (0.9-29.0%) for asthma ever, 14.4% (2.8-45.7%) for hay fever ever and 9.9% (1.6-29.5%) for eczema ever. Centre prevalence varied considerably both between countries and within countries. There was a moderate correlation between hay fever ever and asthma ever, and between eczema ever and hay fever ever at the centre level. There were moderate to strong correlations between indicators of the burden of disease reported in adults and the two younger age groups.
conclusionWe found evidence for a substantial burden of asthma, hay fever ever and eczema ever in the countries examined, highlighting the major public health importance of these diseases. Prevention strategies and equitable access to effective and affordable treatments for these three conditions would help mitigate the avoidable morbidity they cause.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.